Showing results (1591-1600 of 2,121) with videos related to

Sort By:
Pageof 213
Transplantation|April 23, 2011
Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysisMasao Yamasaki, Ryota Sakurai, Atsushi Hirohata, et al.
Schizophrenia Research|February 2, 2006
Gray matter abnormalities associated with duration of untreated psychosisJulia M Lappin, Kevin Morgan, Craig Morgan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 28, 2004
Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 proteinWilliam F Fearon, Fumiaki Ikeno, Lynn R Bailey, et al.
JACC. Cardiovascular Interventions|July 22, 2017
Accuracy of Fractional Flow Reserve Measurements in Clinical Practice: Observations From a Core Laboratory AnalysisMitsuaki Matsumura, Nils P Johnson, William F Fearon, et al.
Schizophrenia Research|September 22, 2010
Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP studyUlrich Reininghaus, Thomas K J Craig, Helen L Fisher, et al.
Psychological Medicine|April 18, 2013
Modelling the interplay between childhood and adult adversity in pathways to psychosis: initial evidence from the AESOP studyC Morgan, U Reininghaus, P Fearon, et al.
Circulation|May 18, 2013
Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary interventionWilliam F Fearon, Adrian F Low, Andy S Yong, et al.
International Journal of Cardiology|April 18, 2017
The effect of negative remodeling on fractional flow reserve after cardiac transplantationWilliam F Fearon, Robert Felix, Atsushi Hirohata, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 3, 2012
Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and functionNathan A Stephens, Calum Gray, Alisdair J MacDonald, et al.
Cancer Cell|June 28, 2002
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformationFrank T Kolligs, Marvin T Nieman, Ira Winer, et al.
Pageof 213